Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization

This study has been completed.
Sponsor:
Information provided by:
Instituto Valenciano de Infertilidad, IVI VALENCIA
ClinicalTrials.gov Identifier:
NCT00447850
First received: March 13, 2007
Last updated: September 18, 2009
Last verified: September 2009

March 13, 2007
September 18, 2009
April 2007
July 2009   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00447850 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization
Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization

Previous studies have suggested that premature luteinization (PL)during controlled ovarian stimulation (COS) decreases the implantation rate due to a negative effect on the endometrium receptivity. This study aims to describe the impact on endometrial gene expression of PL in GnRH antagonist and GnRH agonist cycles.

Not Provided
Interventional
Not Provided
Not Provided
Premature Luteinization
Procedure: endometrial biopsy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
July 2009
July 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Oocyte donors
  • Age between 18-35 years old
  • BMI 18-29
  • NORMOGONADOTROPHICS
  • PROGESTERONE ≥ 1.2 ng/ml on hCG day

Exclusion Criteria:

  • PolyCystic Ovarian Syndrome (PCOS)
  • Endometriosis
Female
18 Years to 35 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Spain
 
NCT00447850
VLC-EL-1006- 307-2
Not Provided
Dr. Elena Labarta, Instituto Valenciano de Infertilidad
Instituto Valenciano de Infertilidad, IVI VALENCIA
Not Provided
Principal Investigator: Elena Labarta, MD Instituto Valenciano de la Infertilidad
Instituto Valenciano de Infertilidad, IVI VALENCIA
September 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP